I've learned over the years if you want to put money in a Biotech company you can't go wrong with Amgen, the rest of them are just a gamble. I checked out your Genta (Biotech company that developes cancer drugs) and on Hoover's it says that Aventis will co-market the drug (Genasense) in the US upon FDA approval. You say Genta has a target of $21 in the next 12-18 months........in your dreams! Needham is just pumping and dumping it!
Looks like they are going to have another bad quarter. Could be a few more going forward if you look deep enough. the dividend does not cover the downside to this stock.(only 1.25% yeild) The sales have been flat from 2000 to 2001 and have been down 10% from 2001 to 2002. They do not have any book value. Not sure about this one except the stock trend and sales seem's to be down. Be carfull of this one.